by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 24, 2024 | News
Exogenus Therapeutics is proud to announce a strategic investment led by 3xP Global. This funding of 3xP Global will significantly advance the development of Exogenus lead product, Exo-101, that derived from umbilical cord blood cells and has shown promise in multiple...
by admin | Dec 13, 2022 | News
Exogenus Therapeutics CEO, Joana Simões Correia, participated in a roundtable organized by Cell & Gene Therapy Insights and Miltenyi, as part of a discussion panel about “Diagnostic & therapeutic uses for extracellular vesicles (EVs): insights into a rapidly...
by admin | Dec 7, 2022 | News
A meeting report from the 2021 massivEVs workshop entitled “Large-scale production of extracellular vesicles: Report on the “massivEVs” ISEV workshop” is now online. The massivEVs workshop took place on October 2021 and addressed the efforts towards large scale EV...
